Explorer
Debate: Experts share key points after vaccine approval
Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
Pune-based Serum Institute of India has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing 'Covishield', while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for 'Covaxin'.
Serum and Bharat Biotech Pfizer had applied for the accelerated approval on December 6 and 7, respectively.
Pune-based Serum Institute of India has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing 'Covishield', while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for 'Covaxin'.
Serum and Bharat Biotech Pfizer had applied for the accelerated approval on December 6 and 7, respectively.
India
Delhi News: Left-Wing Women Protest Outside Police HQ, Allege Harassment During Demonstrations
Delhi News: Traders Claim ₹3,000 Crore Loss Due to Protests, Warn of ₹10,000 Crore Diwali Hit
Delhi News: CJP Founder Abhijeet Deepke to Appear in Court as Left Groups Protest
UP News: Akhilesh Yadav Attacks BJP with 12 Questions on Banks, Loans and Public Money
UP News: Yogi Adityanath Highlights Ancient Indian Values While Addressing Law Students in Lucknow
View More
Trending News



















